Predicting short-term treatment toxicity in head and neck cancer through a systematic review and meta-analysis
Marco A. Mascarella(Jewish General Hospital), Marie‐Jeanne Kergoat(Université de Montréal), Michael P. Hier(McGill University), George Shenouda, Umamaheswar Duvvuri(City University of New York), Shaum Sridharan(University of Pittsburgh), Christina Tsien(McGill University Health Centre), Varun Vendra(University of Pittsburgh Medical Center), Alex Mlynarek(McGill University), Nader Sadeghi(Centre National de la Recherche Scientifique), Khashayar Esfahani(McGill University), Khalil Sultanem(McGill University), Keith Richardson(McGill University), Nathaniel Bouganim(McGill University Health Centre)
Cited by 9
Related Papers
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
A Review of Cancer Immunotherapy: From the Past, to the Present, to the Future
|Current Oncology|2020|941
Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer
|Immunity|2020|688
Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers
|Cancer Discovery|2013|590